The adjuvant activity of Bordetella pertussis was investigated, both at the cellular and humoral levels, when the bacterial adjuvant was given at various times after the primary antigenic stimulus of both 2 X 107 (suboptimal dose) and 4 x 108 (optimal dose) of sheep erythrocytes. 
The adjuvant activity of Bordetella pertussis was investigated, both at the cellular and humoral levels, when the bacterial adjuvant was given at various times after the primary antigenic stimulus of both 2 X 107 (suboptimal dose) and 4 x 108 (optimal dose) of sheep erythrocytes. In all experiments, both adjuvant and sheep erythrocytes were administered by the intraperitoneal route. Adjuvant activity was measured on the basis of the early and late phases of the primary response and on the degree of priming for the secondary immune reaction. A maximal adjuvant activity was found in mice which had received B. pertussis vaccine simultaneously with the antigen. Adiuvant effectiveness became less as the time interval between the injection of antigen and adjuvant increased. Adjuvancy also depended on the amount of antigen used as the primary antigenic stimulus. With 4 x 108 sheep erythrocytes, significantly increased priming for the secondary response was produced only when B. pertussis cells were administered within a period of 24 hr. When the bacterial adjuvant was administered either 48 or 72 hr after the primary antigenic stimulus, adiuvancy was found to be limited to the late phase of the primary response and to the prolonged development of antibody-forming cells during the secondary immune reaction. In contrast, significantly enhanced priming for the secondary response was detectable when the adjuvant was administered as late as 48 hr after primary immunization with 2 X 107 sheep erythrocytes. When the bacterial adjuvant was administered either 6, 24, 48, or 72 hr after the primary immunization with 2 X 107 sheep erythrocytes, the early phase of the primary 19S and 7S hemolysin response was found to be suppressed, and adjuvancy became detectable only thereafter.
Killed Bordetella pertussis cells act as adjuvant in man and animals (4, 13, 18, 21) , but the mode of action of these bacteria and other types of immunological adjuvants is still unknown. Studies at the cellular level have shown that the adjuvancy of B. pertussis is mainly due to the prolonged multiplication of antibody-forming cells (10, 11) . It has been demonstrated that immunoglobulin G (IgG)-producing cells are more sensitive to the adjuvant activity of pertussis organisms than immunoglobulin M (IgM) producers (2, 11) . One of the most important aspects regarding the mode of action of immunological adjuvants is the time relationship between injection of antigen and adjuvant. In a recent study, significant adjuvancy was demonstrated when B. pertussis cells were administered within a period of 48 hr before injection of antigen (6) . In this paper we investigate the question of how long after primary immunization B. pertussis cells can be injected and yet be capable of effecting adjuvancy. The necessity for such studies comes from the contradictory findings obtained by several authors under widely different experimental conditions (2, 4, 9, 25, 27) . Thus, the present study was performed to explore, at both the cellular and humoral levels, whether or not significant adjuvancy of B. pertussis is detectable, when it is administered at different times after primary immunization with either a suboptimal or an optimal dose of sheep erythrocytes. Thereby, adjuvancy was evaluated on the basis of the early and late phases of the primary immune reaction and on the extent of priming for the secondary response. (28) antibody plaque techniques were used, as described previously (6, 8) . The calculation of indirect PFC was done by the method of Wortis, Taylor, and Dresser (28) . It is generally accepted that the majority of direct PFC represents 19S hemolysin-producing cells (28) , whereas most of the indirect PFC are considered to be 7S hemolysin producers (3, 23, 28) . As described in a previous paper (6), the total cell counts in the spleens were calculated from the deoxyribonucleic acid (DNA) contents determined by the method of Burton (1) .
Spleen index. Wet spleen weights were determined gravimetrically. The spleen index is defined as wet spleen weight/body weight (mg/g).
Serological methods. Serum hemolysin activity was determined spectrophotometrically at 530 nm by the 50% hemolysis method (26) in pooled serum samples from the controls and from groups of identically treated mice. Hemolysin concentrations are given in 50% hemolysis units (HU) per milliliter of serum. In addition, those fractions of the total hemolysin activity resistant to treatment with 0.125 M 2-mercaptoethanol (2-ME) were determined. The lowest value considered significant was found to be 10 HU (14) . Total and 2-ME-resistant hemagglutinating antibody titers of pooled sera were assayed by a standard tube method. Experimental procedures. At different intervals after the primary and secondary immunization, six to seven mice out of each group and two animals of the untreated controls were killed, the spleens were removed, and the sera were collected. About one-half of the spleens were employed for the determination of the DNA contents. The sera were stored at -20 C until used.
RESULTS
In the first series of experiments, the effects of B. pertussis as adjuvant on the immune response to optimal doses of sheep erythrocytes were inves- cases were characterized by the predominant development of indirect PFC, whereby the corresponding maximum values of direct PFC amounted to either 19% (group I), 15% (group II) or 12% (group III) of those of the indirect PFC. In group I the peak value of indirect PFC was found on day 3, but in the PO-treated groups only on 1 respect to the peak values of direct and indirect PFC there was no significant difference among the three experimental groups in the secondary reaction (Fig. 4) . (group II), and 6,246 i 828 (group Ill). There was, however, a delayed decrease of indirect PFC in both PO-treated mouse groups. As compared to the total numbers of indirect PFC found on day 5 after boostering in the spleens of group I (249,000 34,700), the corresponding values of group II (1,050,000 219,000) and group m (424,400 zi 118,000) differed with statistical significance (group II: t = 2.63, 2P < 0.025; group HI: t = 2.49, 2P <0.05). Accordingly, the bemolysin titers determined in the pooled sera of group II (total: 850 HU; 2-MEresistant: 740 HU) and group III (total: 594 HU; 2-ME-resistant: 547 HU) were found to be higher than those of group I (total: 347 HU; 2-ME-resistant: 324 HU).
The data obtained by experiments A and B indicate that maximal adjuvant activity is found in mice which received B. pertussis vaccine simultaneously with the antigen. Adjuvant effectiveness became less as the time interval between injection of antigen and adjuvant increased. Thus, significantly increased priming for the secondary response was produced only when B. pertussis ceUls were administered within a period of 24 hr. When PO were injected 48 or 72 hr after the primary antigenic stimulation with 4 X 108 SE, adjuvancy was found to be limited to the late phase of the primary response and to the prolonged development of antibody-forming cells during the secondary immune reaction. The following experiments were performed to find out whether or not adjuvancy of PO also depends on the amount of antigen used as the primary antigenic stimulus.
Experiment C. Four groups of mice were used in this experiment and were primarily immunizd by an ip injection of 2 X 107 SE. The animals of group I received no further injection, whereas the other mice were treated with 3 X 109 PO simultaneously (group II), or 6 hr (group HI) or 24 hr (group IV) after the primary immunization. Mice of all groups were given a booster dose of 4 X 108 SE 35 days after priming.
(i) Primary immune response (C). Compared to the injection of 2 X 107 SE (group I), an additional injection of PO (groups II to IV) led again to a significant elevation of the spleen weights during the period of observation from day 3 to day 12. Furthermore, the spleens of mice which had received PO simultaneously with SE (group II) contained increased numbers of direct and indirect PFC on all days tested (Fig. 5) . If PO were injected either 6 hr (group Ill) or 24 hr (group IV) after primary immunization, the total numbers of direct PFC determined on day 3 were found to be significantly reduced, as compared to those of the control group I. During the following period only slight adjuvancy, limited to the direct PFC, was seen in these mouse groups until day 10; but on day 12 both the cellular 19S and 7S responses were found to be significantly increased, as compared to the control group I (Fig. 5) .
(ii) Secondary immune response (C). The secondary injection of 4 x 108 SE was given 35 days after primary immunization. In the control group I, peak numbers of indirect PFC were determined on day 4 ( 
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(ii) Secondary immune response (D). In group SECONDARY I the relative peak value of direct PFC was found , INJECTION on day 3 after secondary antigenic stimulation X: 10 (896 ± 228), which differed significantly (2P <0.05) from that of group II (2,436 i 534), but 2 not from that of group 1I (996 ±t 223) (Fig. 6 ). 1 / Thereafter the relative numbers of direct PFC L decreased rapidly with the group I, but only slowly with the PO-treated groups II and III. 10 Thus, the relative numbers of direct PFC found ES on day 4 Thereby the mean peak value of group II (11,592 C i 916) was significantly greater (2P <0.02) than _ 102/ that of group I (6,342 ± 1,230). The same holds / true for the mean value found on day 6 in group C/ II (3,344 + 796), as compared to that of group , 101 I (800 i 207) (Fig. 6) . The (27) . Other studies led to the finding that neither increased plaque counts nor serum hemolysin titers became detectable during a 20-day period of observation, when B. pertussis organisms were given 6, 12, or 24 hr after primary immunization of NMRI mice with 8 X 106 SE, which represents only little more than an immunogenic threshold dose (9) . Unfortunately, in this study no tests were performed regarding the question of whether or not priming for the secondary response was increased under such experimental conditions (9) . Finally, it has been reported that B. pertussis cells injected either 1, 3, or 5 days after primary immunization of CBA mice with 4 X 107 SE led to a poor increase of the primary hemolysin response at the cellular level (2) . Contradictory findings were likewise obtained with regard to bacterial endotoxins, as can be seen from the review of Neter (22) . In rabbits adjuvant action was apparent when the endotoxin was given up to 2 to 3 days after a soluble protein antigen (16, 17) . Using Balb mice, the hemagglutinating serum antibody titers were found to be enhanced when Serratia marcescens endotoxin was injected as long as 6 days after administration of a purified protein antigen (19) . In contrast, Franzl and McMaster (12) were not able to detect adjuvancy in several series of experiments when the endotoxin was injected into mice 1 or 2 days after primary immunization with 2 X 107 SE. In some cases even marked suppression of the primary hemolysin response was found under such experimental conditions, whereby the amount of endotoxin administered and the route of injection of antigen and endotoxin were suggested to be the critical factors. With respect to these discrepancies it has been argued that they are possibly due to the different sensitivities of the various animal species tested (22) . We feel, however, that besides the different procedures employed for measuring adjuvancy in various animal species, the dose of antigen might be of significant importance to the posed question. Moreover, we believe that studies on adjuvancy of a given material demand not only several tests during the early and late phases of the primary immune response, but, in addition, investigations regarding the extent of priming for the secondary immune reaction.
As compared to the primary immunization of mice with 2 X 107 (suboptimal dose) or 4 X 108 SE (optimal dose), the additional injection of B. pertussis cells administered simultaneously with the erythrocyte antigen caused a significantly increased and prolonged multiplication of direct and indirect PFC per one million spleen cells, most pronounced with respect to the IgG-producing cells. This is in accordance with previous findings (2, 11) . Even a greater increase in the numbers of antibody-forming cells was demonstrable in pertussis-treated mice when the total numbers of hemolysin-forming cells per spleen were determined. This is evidently due to the significant multiplication of spleen cells regularly observed after the injection of B. pertussis cells (5) (6) (7) . Furthermore, the bacterial adjuvant increased significantly the process of priming for the secondary response. When the B. pertussis vaccine was administered within a period of 72 hr after primary antigenic stimulation, elevation of the spleen weights was regularly observed, whereas adjuvant activity was found to be more and more reduced the longer the time interval between injection of antigen and adjuvant. How There now exists evidence for the necessity of a two-cell (20) or a three-cell interaction (24) in the initiation of the primary immune response. The data presented here do not yield direct information concerning the question as to which of the cell types is mainly affected by the adjuvant.
